These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38951067)
1. [Analysis of therapeutic effects of allogeneic hematopoietic stem cell transplantation in 12 patients with DEK-NUP214 fusion gene positive acute myeloid leukemia]. Shen YY; Yang DL; He Y; Pang AM; Chen X; Ma QL; Zhang RL; Wei JL; Zhai WH; Han MZ; Jiang EL; Feng SZ Zhonghua Xue Ye Xue Za Zhi; 2024 Apr; 45(4):383-387. PubMed ID: 38951067 [TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of gilteritinib-based combination therapy bridging allo-HSCT in relapsed or refractory acute myeloid leukemia patients with positive FLT3-ITD mutation]. Xu Y; Zhang J; Xue SL; Miao M; Wang Y; Chen SN; Qiu HY; Wu DP Zhonghua Xue Ye Xue Za Zhi; 2024 Apr; 45(4):357-363. PubMed ID: 38951063 [No Abstract] [Full Text] [Related]
3. [Analysis of the therapeutic effect of avatinib bridged allogeneic hematopoietic stem cell transplantation on 7 cases of recurrent/refractory RUNX1-RUNX1T1 positive acute myeloid leukemia with KIT mutations]. Han SY; Zhou HX; Han Y; Wu DP Zhonghua Xue Ye Xue Za Zhi; 2024 Aug; 45(8):767-771. PubMed ID: 39307724 [No Abstract] [Full Text] [Related]
4. [Analysis of the efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome with blastomycosis and survival comparison of different subtypes after the WHO 2022 reclassification]. Wang H; Ma RZ; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):445-452. PubMed ID: 38964918 [No Abstract] [Full Text] [Related]
6. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
7. Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial. Kwiatkowski JL; Walters MC; Hongeng S; Yannaki E; Kulozik AE; Kunz JB; Sauer MG; Thrasher AJ; Thuret I; Lal A; Tao G; Ali S; Thakar HL; Elliot H; Lodaya A; Lee J; Colvin RA; Locatelli F; Thompson AA Lancet; 2024 Nov; 404(10468):2175-2186. PubMed ID: 39527960 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of venetoclax combined with decitabine, modified HA regimen and DLI in the treatment of relapsed pediatric AML/MDS after allogeneic hematopoietic stem cell transplantation]. Zhang F; Wang HF; Hu GH; Suo P; Bai L; Wang Y; Zhang XH; Huang XJ; Cheng YF Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):832-837. PubMed ID: 39414606 [No Abstract] [Full Text] [Related]
9. Efficacy of Ruxolitinib with corticosteroids in idiopathic pneumonia syndrome post-allogeneic hematopoietic stem cell transplantation: A single-center experience and systematic review. Shahzad M; Khan MA; Amin MK; Sarfraz Z; Zulfiqar F; Qasim H; Bansal R; Brownback K; Ahmed N; Abhyankar SH; McGuirk JP; Singh AK; Mushtaq MU Transpl Immunol; 2024 Dec; 87():102135. PubMed ID: 39368752 [TBL] [Abstract][Full Text] [Related]
10. Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial. Short NJ; Nguyen D; Jabbour E; Senapati J; Zeng Z; Issa GC; Abbas H; Nasnas C; Qiao W; Huang X; Borthakur G; Chien K; Haddad FG; Pemmaraju N; Karrar OS; Nguyen D; Konopleva M; Kantarjian H; Ravandi F Lancet Haematol; 2024 Nov; 11(11):e839-e849. PubMed ID: 39303729 [TBL] [Abstract][Full Text] [Related]
11. [Retrospective clinical study on cryopreservation-free integrated autologous hematopoietic stem cell transplantation model for newly diagnosed multiple myeloma]. Yang X; Li CL; Chen J; Che FF; Xiao R; Li H; Huang J; Jiang T; Yang HQ; Wang H; Kuang XC; Huang XB Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):488-494. PubMed ID: 38964924 [No Abstract] [Full Text] [Related]
12. Minimally Invasive Transforaminal Versus Lateral Lumbar Interbody Fusion for Degenerative Spinal Pathology: Clinical Outcome Comparison in Patients With Predominant Back Pain. Jacob KC; Patel MR; Hartman TJ; Nie JW; Parsons AW; Ribot MA; Prabhu M; Pawlowski H; Vanjani N; Singh K Clin Spine Surg; 2024 Dec; 37(10):E441-E447. PubMed ID: 39450893 [TBL] [Abstract][Full Text] [Related]
13. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
14. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis. Curry N; Davenport R; Thomas H; Fox E; Lucas J; Evans A; Massou E; Sharma R; Shanmugaranjan S; Rourke C; Newton A; Deary A; Dallas N; Fitzpatrick-Creamer C; Podbielski JM; Wade CE; Edwards A; Benger J; Morris S; Cotton BA; Piercy J; Green L; Brohi K; Stanworth S Health Technol Assess; 2024 Nov; 28(76):1-69. PubMed ID: 39545850 [TBL] [Abstract][Full Text] [Related]
15. [The efficacy and safety of avapritinib in the treatment of molecular biologically positive core binding factor-acute myeloid leukemia with KIT mutation after allogeneic hematopoietic stem cell transplantation]. Wang J; Zu YL; Gui RR; Li Z; Zhang Y; Zhou J Zhonghua Xue Ye Xue Za Zhi; 2024 Aug; 45(8):761-766. PubMed ID: 39307723 [No Abstract] [Full Text] [Related]
16. [Clinical efficacy of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome-evolved acute myeloid leukemia]. Chen SL; Shi YY; Zhang LN; Gong M; Zhang XY; Zhao XL; Hao MZ; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL Zhonghua Xue Ye Xue Za Zhi; 2024 Apr; 45(4):364-369. PubMed ID: 38951064 [No Abstract] [Full Text] [Related]
17. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity? Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223 [TBL] [Abstract][Full Text] [Related]
18. Uniform Graft-versus-Host Disease Prophylaxis using Post-Transplantation Cyclophosphamide, Methotrexate, and Cyclosporine following Peripheral Blood Hematopoietic Stem Cell Transplantation from Matched and Haploidentical Donors for Transfusion-Dependent Thalassemia: A Retrospective Report from the Bone Marrow Failure Working Group of Hunan Province, China. Gong S; Tian X; Yang R; Yang L; Wang Z; Yang K; Chen K; He X; Deng W; Yang X; Lei M; Fu B Transplant Cell Ther; 2024 Dec; 30(12):1213.e1-1213.e12. PubMed ID: 39236789 [TBL] [Abstract][Full Text] [Related]
19. Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study. Jiang S; Lu X; Wei R; Zhang A; Chen H; Shi W; Xia L Ann Hematol; 2023 Nov; 102(11):3205-3216. PubMed ID: 37682324 [TBL] [Abstract][Full Text] [Related]
20. Effect of ABO Mismatch and Red Blood Cell Alloimmunization on the Outcome of Hematopoietic Cell Transplantation for Sickle Cell Disease. Saib I; Alahmari B; Alsadi H; Alaskar A; Hejazi A; Salama H; Al Raiza A; Saleh ASA; Ibrahim A; Bakkar M; Ghori A; Alsuhaibani A; Alharbi A; Alanazi T; Ahmed R; Shehabeddine I; Alkhraisat S; Alharbi A; Mahasneh I; Ballili M; Aljubour Z; Ahmed M; Alzahrani M Transplant Cell Ther; 2024 Nov; ():. PubMed ID: 39522720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]